Reporting Manager
Dr. Maha Katabi ("Katabi")
Symbol
VERA
Shares outstanding
71,195,925 shares
Disclosed Ownership
2,847,837 shares
Ownership
4%
Form type
SCHEDULE 13D/A
Filing time
05 Mar 2026, 06:11:20 UTC
Date of event
10 Dec 2025

Sponsored

Quoteable Key Fact

"Sofinnova Venture Partners X, L.P. disclosed 4% ownership in Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value (VERA) on 10 Dec 2025."

Quick Takeaways

  • Sofinnova Venture Partners X, L.P. filed SCHEDULE 13D/A for Vera Therapeutics, Inc. Class A Common Stock, $0.001 par value (VERA).
  • Disclosed ownership: 4%.
  • Date of event: 10 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 05 Mar 2026, 06:11.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sofinnova Venture Partners X, L.P. ("SVP X") 3.9% 2,793,987 2,793,987 0 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact 0001680200
Sofinnova Management X, L.P. ("SM X LP") 3.9% 2,793,987 2,793,987 0 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact
Sofinnova Management X-A, L.L.C. ("SM X LLC") 3.9% 2,793,987 2,793,987 0 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact
Dr. James I. Healy ("Healy") 3.9% 2,793,987 0 2,793,987 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact
Dr. Maha Katabi ("Katabi") 4% 2,847,837 53,850 2,793,987 /s/ Nathalie Auber Nathalie Auber / Attorney-in-Fact